Cosmetic composition comprising a plant extract

An aqueous extract of Pisum sativum L. plants, cultivated and extracted without solvents, addresses the need for effective skin restoration by enhancing skin barrier function and hydration, reducing pores, and combating aging through optimized niacinamide stimulation.

WO2026234096A1PCT designated stage Publication Date: 2026-11-12NAEMOS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2026/063101
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-05-06
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing cosmetic agents fail to effectively restore the skin's barrier function, combat skin aging, reduce the visibility of pores and skin imperfections, and improve hydration, particularly due to the lack of agents that stimulate physiological mechanisms related to skin health.

Method used

An aqueous or hydro-alcoholic extract of Pisum sativum L. plants, cultivated under controlled conditions and extracted using microwave and maceration methods without additional solvents, containing optimized levels of niacinamide, is used to stimulate biological pathways related to skin barrier function, skin laxity, and hydration.

Benefits of technology

The extract enhances skin barrier function, reduces pore visibility, combats skin aging, and improves hydration by stimulating ceramide synthesis and enzyme expression, while minimizing environmental impact and production costs through solvent-free extraction.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000026_0001_TABLE
    Figure IMGF000026_0001_TABLE
  • Figure IMGF000027_0001_TABLE
    Figure IMGF000027_0001_TABLE
  • Figure IMGF000028_0001_TABLE
    Figure IMGF000028_0001_TABLE
Patent Text Reader

Abstract

The invention relates to an aqueous, aqueous-alcoholic or alcoholic extract, preferably an aqueous extract, of at least one plant or at least one part of a plant of the Pisum genus, to the method for obtaining same, to a composition containing same, and to various uses thereof, in particular cosmetic uses.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] DESCRIPTION

[0002] TITLE: Cosmetic composition comprising a plant extract

[0003] The invention relates to an aqueous, hydro-alcoholic or alcoholic extract, and in particular an aqueous extract, of at least one plant or at least part of a plant of the genus Pisum, its method of obtaining it, a composition containing it, as well as various uses, including cosmetics.

[0004] The skin is a semi-permeable protective layer that prevents water loss, thus ensuring adequate hydration and protecting the body against the migration of microorganisms through the skin. Therefore, the epidermis acts as a moisture barrier, but also protects the body from the environment.

[0005] However, age and many external aggressions, such as exogenous factors (solar radiation, air pollution, tobacco smoke, nutrition or temperature) and endogenous factors (lack of sleep or stress), can lead to molecular processes that are detrimental to the structure of the skin.

[0006] There is always a need for new agents, particularly in the cosmetic field, and especially those capable of restoring the skin's barrier function, preventing and / or combating skin aging, particularly against skin sagging, reducing the visibility of pores and skin imperfections and / or improving skin hydration.

[0007] However, the Applicant found that an aqueous, hydro-alcoholic or alcoholic extract of at least one plant or at least part of at least one plant of the genus Pisum exhibits interesting and unexpected activities through the stimulation of physiological mechanisms.

[0008] Indeed, as demonstrated in the examples below, the extract of at least one plant or at least part of at least one plant of the genus Pisum according to the invention, thanks in particular to culture conditions, notably made possible by vertical culture, and to an optimized extraction method, allows a significant stimulation of biological pathways related to the skin barrier function, skin laxity, particularly related to age, the visibility of pores and skin imperfections, and skin hydration, such as the synthesis of ceramides, the expression of the hyaluronan synthase 2 (HAS2) enzyme responsible for the production of hyaluronic acid in the skin and the expression of the superoxide dismutase 1 (SOD1) enzyme whose function is to dismutate the superoxide anion, one of the toxic by-products of mitochondrial respiration.An extract of at least one plant or at least part of at least one plant of the genus Pisum according to the invention therefore has an effect on the skin's barrier function, skin laxity, the visibility of pores and skin imperfections and skin hydration.

[0009] The invention therefore relates, according to a first aspect, to an aqueous, hydroalcoholic or alcoholic extract, and in particular an aqueous extract, of at least one plant or at least part of at least one plant of the genus Pisum, said extract comprising at least 0.05%, preferably at least 0.10%, in particular at least 0.15%, or even at least 0.18%, in particular at least 0.20%, and better at least 0.30%, and most particularly at least 0.40%, by weight of niacinamide relative to the total dry weight of the extract.

[0010] In particular, the invention relates to an aqueous, hydro-alcoholic or alcoholic extract, and in particular an aqueous extract, of at least one plant or at least part of at least one plant of the genus Pisum comprising between 0.05% and 0.7% by weight of niacinamide relative to the total dry weight of the extract, preferably between 0.20% and 0.60% by weight of niacinamide relative to the total dry weight of the extract, more preferably between 0.30% and 0.50% by weight of niacinamide relative to the total dry weight of the extract.

[0011] The advantageous and unexpected nature of such an extract is directly correlated to the choices and optimizations, in particular, at the level of the culture conditions, notably made possible by vertical culture, and of the extraction method, as described in more detail below.

[0012] Preferably, the plant in question is of the species Pisum sativum L. or Pisum fulvum Sm, and preferably Pisum sativum L.

[0013] The invention also relates, according to a second aspect, to a method for obtaining at least one extract according to the invention, characterized in that it comprises at least the following steps according to which:

[0014] (a) at least one plant or at least part of at least one plant of the genus Pisum is available, optionally in crushed and / or frozen form;

[0015] (b) the plant or plant part from step (a) is subjected to at least one extraction cycle comprising:

[0016] (b1) at least one microwave extraction step, optionally with stirring; and / or

[0017] (b2) at least one maceration extraction step, optionally under agitation;

[0018] preferably steps (b1) and (b2), when both are present, being carried out within the same extraction device; (c) optionally, the extract obtained in step (b) is purified by filtration, ultrafiltration and / or nanofiltration; and

[0019] (d) Optionally, the extract obtained in step (b), or in step (c), is redispersed in a preservation solvent.

[0020] The invention also relates to an extract according to the invention, preferably aqueous, obtainable by such a process. Advantageously, the invention relates to an aqueous, hydro-alcoholic, or alcoholic extract, preferably aqueous, of at least one plant of the genus Pisum, characterized in that it can be obtained by a process according to the invention.

[0021] The invention relates to a non-therapeutic use, in particular cosmetic, of at least one extract according to the invention, to restore the skin's barrier function, prevent and / or combat skin aging, in particular against skin sagging, reduce the visibility of pores and skin imperfections and / or improve skin hydration.

[0022] The invention further relates to a composition, in particular cosmetic, pharmaceutical, nutraceutical or food, and preferably cosmetic, comprising at least one extract according to the invention or obtained by means of a process of obtaining according to the invention, optionally in association with at least one physiologically acceptable medium.

[0023] Preferably, the extract or composition, in particular cosmetic according to the invention, is administered (or adapted for application) orally or topically, and preferably topically.

[0024] The invention further relates to a non-therapeutic cosmetic treatment process, in particular for makeup and / or care, of a keratinous material, in particular of the skin, lips or hair, comprising at least one step of applying to said keratinous material at least one extract according to the invention or a composition according to the invention.

[0025] Plant of the genus Pisum

[0026] The raw material used in the present invention consists of at least one plant or at least part of at least one plant of the genus Pisum. The genus Pisum belongs to the legume family (Fabaceae). The raw material used in the present invention consists of at least one plant or at least part of at least one plant selected from the pea. Preferably, the raw material used in the present invention therefore consists of at least one plant or at least part of at least one plant of the species Pisum sativum L. or Pisum fulvum Sm., and preferably Pisum sativum L.

[0027] The species Pisum sativum exhibits very high genetic diversity, which is reflected in the numerous variations in the morphological characteristics of its flowers, leaves, stems, pods, and seeds. The main subspecies and varieties are:

[0028] - Pisum sativum L. subsp. elatius, to which the variety pumilio is related;

[0029] - Pisum sativum L. subsp. Elatius, var. pumilio Meikle (syn. Pisum sativum subsp. syriacum Berger): most xerophytic subspecies;

[0030] - Pisum sativum subsp. transcaucasicum Govorov;

[0031] - Pisum sativum L. subsp. abyssinicum (or Abyssinian pea);

[0032] - Pisum sativum subsp. asiaticum Govorov;

[0033] - Pisum sativum L. subsp. sativum: this is the most important subspecies, which derives through domestication from the form Pisum sativum subsp. elatius. It has three main varieties: Pisum sativum L. subsp. sativum var. arvense (L.) Poir.; Pisum sativum L. subsp. sativum var. sativum; and Pisum sativum L. subsp. sativum var. macrocarpon.

[0034] Preferably, the raw material used in the present invention is Pisum sativum L. subsp. Sativum.

[0035] Extract extraction process

[0036] In particular, the extract according to the invention can be obtained by means of a process for obtaining at least one extract according to the invention, characterized in that it comprises at least the following steps according to which:

[0037] (a) at least one plant or at least part of at least one plant of the genus Pisum is available, optionally in crushed and / or frozen form;

[0038] (b) the plant or plant part from step (a) is subjected to at least one extraction cycle comprising:

[0039] (b1) at least one microwave extraction step, optionally with stirring; and / or

[0040] (b2) at least one maceration extraction step, optionally under agitation;

[0041] preferably steps (b1) and (b2), when both are present, being carried out within the same extraction device; (c) optionally, the extract obtained in step (b) is purified by filtration, ultrafiltration and / or nanofiltration; and

[0042] (d) Optionally, the extract obtained in step (b), or in step (c), is redispersed in a preservation solvent.

[0043] Preferably, a method of obtaining according to the invention does not include a concentration step and / or a purification step of the extract obtained in step (b), (c) or (d).

[0044] The advantageous and unexpected nature of an extract according to the invention derives in particular from step (a) of the process according to the invention and more particularly from optimized culture conditions, which in fact make it possible to access a plant or part of a plant, dedicated to be used for step (b) of extraction of the process of obtaining according to the invention, comprising optimized levels of niacinamide while maintaining satisfactory culture yields (or production yield), which is particularly important when considering the invention on an industrial scale.

[0045] The advantageous and unexpected nature of an extract according to the invention may further result from step (b) of extraction, and in particular from the optimized extraction conditions identified by the inventors.

[0046] The advantageous and unexpected nature of an extract according to the invention can further result from the fact that the method of obtaining it, according to a particularly preferred embodiment, is based on an extraction cycle in "native water", that is to say carried out without the addition of extraction solvent, and therefore carried out solely thanks to the water which is an integral part of the plant from the beginning, and in particular the water which is an integral part of the plant cells.

[0047] The advantageous and unexpected nature of an extract according to the invention finally stems from the fact that the process of obtaining it, after the extraction step (b), does not include a concentration step and / or a purification step generally implemented in the manufacture of plant extracts.

[0048] Such concentration and / or purification steps are well known to those skilled in the art. Examples include column chromatography, high-performance liquid chromatography (HPLC), liquid-liquid extraction, and precipitation. These concentration and / or purification steps involve solvents, generally organic solvents such as methanol, ethanol, acetone, ethyl acetate, chloroform, dichloromethane, and mixtures thereof, which are known to be hazardous and / or polluting.

[0049] The ability of a production process according to the invention to dispense with a concentration step and / or a purification step after the extraction step (b) results directly from the combination of the advantages inherent in steps (a) and (b) of the production process according to the invention.

[0050] The present invention is therefore particularly advantageous in that it provides access to an extract containing satisfactory levels of niacinamide from a production process which, after extraction step (b), is devoid of a concentration step and / or a purification step, or even a step involving the addition of extraction solvent. The present invention is all the more advantageous because this absence of a concentration step and / or a purification step, or even a step involving the addition of extraction solvent, allows:

[0051] - a simplification of the production process,

[0052] - a reduction in the production costs of the extract,

[0053] - an improvement in the ecological impact of the production process,

[0054] - improved safety for operators, and

[0055] - access to an extract free from traces of concentration and / or purification solvents, and in particular free from traces of methanol, ethanol, acetone, ethyl acetate, chloroform, dichloromethane, and mixtures thereof, without prejudice to the concentration (or content) of niacinamide.

[0056] However, the prior art does not describe any plant extract or plant part of the genus Pisum, and particularly of the species Pisum sativum, presenting similar quantities of niacinamide, obtained with an extraction process devoid of concentration steps and / or purification steps subsequent to the extraction step, and therefore devoid of dangerous and / or polluting organic solvents, even in trace amounts.

[0057] Step (a)

[0058] The plant of the genus Pisum in step (a) is cultivated according to any method known to a person skilled in the art.

[0059] Preferably, the plant of the genus Pisum in step (a) is cultivated using a vertical cultivation method / device.

[0060] Preferably, the plant of the genus Pisum in step (a) is cultivated using a hydroponic or aquaponic cultivation process / device.

[0061] Preferably, the Pisum plant in step (a) is cultivated under controlled conditions, preferably in a cultivation unit ensuring control of growing conditions, in particular ensuring controlled regulation of water, humidity, temperature, and air quality and light supply, and in particular in which the plant of step (a) has been obtained by hydroponic or aquaponic culture.

[0062] By "controlled conditions", in the context of the present invention, we mean an enclosure (or "unit") in which at least the water and hydrometric parameters, the light, the temperature, the nature and / or composition of the substrate or fertilizing solution, and the air quality are controlled and monitored, if necessary by computer.

[0063] These controlled conditions allow the creation of different combinations of culture conditions to evaluate the influence of one or more parameters on plant growth and the synthesis of molecule(s) of interest.

[0064] These cultivation methods also have numerous ecological advantages because they allow, in particular:

[0065] - a reduced land footprint compared to conventional crops thanks to the stacking of the growing area;

[0066] - preservation of soils and groundwater through the hydroponic nature of the growing system;

[0067] - a 95% water saving compared to conventional crops because the water is recycled by a water recovery system;

[0068] - pesticide-free cultivation because the controlled indoor environment prevents the presence of pests within the crops; and / or

[0069] - an improvement in the concentration of molecules of interest due to optimizations in culture conditions, made possible in particular by vertical culture, and in the extraction method, as described in more detail below.

[0070] These cultivation methods, combined with a green extraction process as described below, thus allow the production of efficient optimized extract with a greatly reduced environmental impact compared to more traditionally developed plant extracts.

[0071] Thus, step (a) of a production process according to the invention is advantageously carried out from a plant of the genus Pisum cultivated in a cultivation unit ensuring total control of the growing conditions, in particular ensuring controlled regulation of water, humidity, temperature, and air quality and light supply.

[0072] Regarding the water parameter, the water used for plant cultivation can be chosen from any suitable water source, and in particular from municipal water, rainwater, or aquifer water. If necessary, the water can be treated before use, notably to remove any traces of contamination, especially pesticides. Specifically, the water is purified by ultraviolet light, filters (preferably with 0.2-micron pore diameter), self-purifying microorganisms such as daphnia (also known as "water fleas"), and mixtures thereof. The water is represented by a fertilizing solution comprising demineralized water and minerals. The pH of the fertilizing solution can also be adjusted by adding acid or base.

[0073] Regarding lighting, sunlight and / or artificial light, particularly LED technology, can be used. An artificial lighting system is especially advantageous because it allows for variations in color, wavelength, power, and / or intensity, thus modifying the composition of the light spectrum illuminating the plants. An artificial lighting system can include a fluorescent lighting strip to generate UV light, specifically between 280 and 400 nm.

[0074] Regarding the atmospheric parameter, the unit can be adapted to inject air of controlled quality, temperature and / or humidity.

[0075] Regarding the temperature parameter, a heating or air conditioning system can be used, possibly reversible.

[0076] The unit is also advantageously suited to operate in a self-sufficient manner, meaning that it produces the energy source(s) necessary for its operation. In particular, the energy used to power a unit according to the invention is clean energy (also called green energy), that is, a primary energy source that produces a low quantity of pollutants when converted into final energy and then used as such. Preferably, the energy used to power a unit according to the invention is chosen from solar energy, including photovoltaic and thermal energy, wind energy, tidal energy, wave energy, hydroelectric energy, geothermal energy, space-based solar energy, nuclear energy, and biomass, preferably solar energy.

[0077] Thus, step (a) of a method for obtaining the product according to the invention is advantageously carried out using a plant of the genus Pisum obtained by hydroponic or aquaponic cultivation. By way of illustration, a suitable agricultural system is a hydroponic system such as that described, for example, in EP0010836, WO1996032835, W02016072042, US2017049064. Another suitable agricultural system is an aquaponic system such as that described, for example, in WO2015160966 or W02008006172.

[0078] A person skilled in the art will know how to make the necessary adjustments to the unit to meet the "controlled conditions" criterion and ensure the cultivation of the plant.

[0079] A cultivation unit such as the one described above is advantageous in that it allows:

[0080] - to reduce, or even prevent, the risks of disease and / or contamination, - to limit the use of pesticides, or even to eliminate them entirely, and to avoid any contamination by pesticides from surrounding crops,

[0081] - year-round plant cultivation, with increased production yields because they are not subject to temperature variations, rain, hail, frost and / or predatory insects,

[0082] - remote control via computer,

[0083] - a reduction in the need for elements necessary for plant growth, - extraction from fresh plants, therefore rich in active ingredients of interest, and moreover in an undegraded form,

[0084] - the recycling of certain organic waste and excreta, particularly from cultivation and extraction stages, to contribute in whole or in part to the growth of future generations of plants, and

[0085] - to limit the use of costly transport and storage chains involving vehicles, machinery, fuels and packaging, implying a reduction in CO2 emissions and the need for energy and fossil carbon, and therefore a reduction in the impact on nature and costs.

[0086] According to a particular embodiment, the plant of the genus Pisum in stage (a) is at a stage of germinated seed (also called germination), microgreen or young shoot, generally grown without soil, and preferably microgreen.

[0087] A sprouted seed is a very early stage of maturity where the plant has a root system, but the cotyledon leaves are not yet developed or are very underdeveloped. The average growing time for most sprouted seeds is less than 10 days, and sometimes less than 5 days, from sowing to harvest. Sprouted seeds have superior properties, particularly nutritional ones, compared to dry seeds: vitamin and enzyme levels can be significantly increased during the germination process.

[0088] A germinated seed is therefore a plant that retains its root system and has an earlier stage of maturity than a microgreen.

[0089] A microgreen is a green vegetable harvested after germination. A microgreen has a single central stem that has been cut just above the soil line during harvesting (and therefore has no roots). It has fully developed cotyledon leaves and usually has a pair of very small, partially developed leaves. The average growing time for most microgreens is 10 to 14 days from sowing to harvest.

[0090] A young shoot is an early stage of maturity, but later than a germinated seed or microgreen. The average growing time for most young shoots is over 10 days, and often over 15 days, from sowing to harvest.

[0091] In general, sprouted seeds, microgreens, and young shoots contain considerably higher levels of vitamins and carotenoids than their mature plant counterparts.

[0092] The very short cultivation time, the very small size (and therefore the small footprint) and the high concentration of active ingredient(s), and in particular of niacinamide, make sprouted seeds, microgreens and young shoots, preferably microgreens, types of plants perfectly suited to the present invention.

[0093] Thus, the extract according to the invention can be obtained from at least one plant or at least part of at least one plant having a growth stage between 5 and 20 days, preferably between 7 and 18 days, and better between 9 and 16 days, or even between 11 and 14 days.

[0094] Preferably, the extract according to the invention is obtained from the roots of the plant, the aerial parts of the plant, and mixtures thereof, and preferably from the aerial parts of the plant.

[0095] Even more preferably, the extract according to the invention is obtained from the leaves, stems, flowers and flowering tops, buds, and mixtures thereof.

[0096] Preferably, the extract according to the invention is obtained from at least one plant or at least part of at least one plant that has been grown with a photoperiod in which at least part of the lighting includes visible light and UV light, preferably between 280 and 400 nm, in particular between 280 and 350 nm, and better between 300 and 325 nm.

[0097] This implicitly indicates that the extract is then preferably obtained from at least one plant or at least part of at least one plant that has been grown in vertical culture, and in particular with a hydroponic or aquaponic cultivation process / device.

[0098] Put another way, in a method of obtaining according to the invention, at least a part of the photoperiod during the cultivation of the plant in step (a) may include illumination with visible light and illumination with UV light, preferably between 280 and 400 nm, in particular between 280 and 350 nm, and better between 300 and 325 nm.

[0099] Preferably, the extract according to the invention is obtained from at least one plant or from at least a part of at least one plant that has been cultivated:

[0100] - with a photoperiod in which light exposure is between 15 hours and midnight, preferably between 16 hours and 23 hours, better between 17 hours and 22 hours, and particularly between 18 hours and 20 hours; and / or - said photoperiod includes at least one period of exposure under illumination comprising visible light and UV light, continuously or intermittently, between 10 hours and 18 hours, preferably between 12 hours and 16 hours, and better between 12 hours and 14 hours; and

[0101] - Optionally, the period of exposure to UV light is stopped between 1 day and 5 days, preferably between 2 days and 4 days, and better 3 days, before harvest.

[0102] Preferably, the duration of exposure under lighting including visible light and UV light represents more than 50%, in particular more than 60%, better more than 70%, especially more than 80%, or even more than 90%, of the total lighting time per day.

[0103] Preferably, the duration of exposure under lighting including visible light and UV light represents between 65% and 90%, and better between 65% and 75%, of the total lighting time per day.

[0104] As the examples below will show, the invention is based in particular on the identification of a particularly interesting and advantageous trade-off between (i) plant stress caused by UV light, which induces niacinamide synthesis, and (ii) biomass yield. Unexpectedly, the inventors observed that the most advantageous and unexpected trade-off is obtained when the plant is exposed to UV light for 12 hours per day, followed by a cessation of UV exposure 3 days before harvest. This pre-harvest "recovery" period appears to allow for a resumption of biomass growth after the stress generated by UV exposure, advantageously and unexpectedly leading to a boost in niacinamide production, probably in response to the UV stress.

[0105] Preferably, the extract according to the invention is obtained from at least one plant or from at least a part of at least one plant that has been cultivated:

[0106] - under irradiation at a light intensity between 100 and 600 pmol / cm² 2 / s, preferably between 150 and 500 pmol / cm 2 / s, and better between 200 and 300 pmol / cm 2 / s ;

[0107] - with a photoperiod in which exposure to light, whether continuous or discontinuous, is between 12 and 24 hours, preferably between 2 and 10 p.m., better between 4 and 8 p.m., and particularly between 6 and 8 p.m.; and / or

[0108] - under irradiation at a luminous intensity having a spectrum comprising between 30% and 5% of the flux in a wavelength between 400 nm and 500 nm, between 30% and 0% between 500 nm and 600 nm, and between 90% and 60% between 600 nm and 700 nm. In a particularly preferred manner, the luminous intensity of visible light has a spectrum comprising between 20% and 10% of the flux in a wavelength between 400 nm and 500 nm, between 15% and 5% between 500 nm and 600 nm, and between 80% and 70% between 600 and 700 nm.

[0109] In a particularly preferred manner, the luminous intensity of UV light is such that 90% of the flux is advantageously found in a wavelength between 300 and 350 nm.

[0110] According to a particularly advantageous embodiment, the exposure to light is less than 24 hours. In other words, the extract according to the invention is obtained from at least one plant or at least a part of at least one plant where the culture phase (i.e., the phase occurring after the germination phase) necessarily includes at least one period of darkness per 24-hour period.

[0111] According to one embodiment, the culture phase can include several different photoperiods, and for example at least two photoperiods. Thus, by way of illustration, after the germination phase which generally takes place in darkness, a first culture phase can be carried out over a period of 4 days with a 16 / 8 photoperiod (i.e. 16 hours of light and 8 hours of darkness), followed by a second culture phase carried out over a period of 8 days with an 18 / 6 photoperiod (i.e. 18 hours of light and 6 hours of darkness).

[0112] In another variant, the light exposure period is continuous. For example, an 18-hour light exposure period will be completed in a single cycle, with a 12-hour exposure period under lighting that includes both visible and UV light, also completed in a single cycle.

[0113] According to yet another variant, the 24-hour exposure period to light, particularly UV light, is carried out discontinuously. For example, an 18-hour daily exposure period would be achieved in at least two cycles, such as a first cycle of 10 hours and a second cycle of 8 hours, these two cycles being separated by a 6-hour dark cycle, with each cycle comprising a 6-hour period of illumination with both visible and UV light.

[0114] The growing temperature is advantageously between 20°C and 30°C, more advantageously between 22°C and 28°C, and better between 24°C and 26°C.

[0115] Step (b)

[0116] Step (b), in particular step (b1), can be carried out using any plant material from the whole plant, or from any part of said plant, such as roots, aerial parts of the plant, and mixtures thereof, and preferably leaves, stems, flowers and flowering tops, seeds, buds, roots, and mixtures thereof.

[0117] Preferably, extraction step (b), in particular step (b1), of a production process according to the invention is carried out from at least one plant or from at least a part of at least one plant:

[0118] - fresh, and preferably a frozen fresh plant; and / or

[0119] - previously dried, freeze-dried, frozen and / or ground, for example in the form of a powder smaller than 2 cm.

[0120] This configuration, using fresh or even frozen plants, advantageously reduces, or even prevents, a degradation in production yield and / or extract quality. Indeed, it is known that some active agents are difficult to preserve over time. This can be explained, in particular, by the development of biochemical mechanisms of tolerance to abiotic stresses, such as water and / or oxidative stress, which can lead to alteration or consumption of these active agents by the plant itself, or even to the production of unwanted molecules that may interact negatively with the active agent of interest. Now, for obvious reasons, the longer the time between harvesting the plant and extracting the active agent(s) it contains, the more the production yield and / or the quality of the active agent(s) can be affected.

[0121] For the purposes of this invention, "fresh" means a plant that has been harvested (for example, picked, pulled up, or extracted from the ground) less than 24 hours, preferably less than 12 hours, in particular less than 5 hours, better less than 3 hours, or even less than 1 hour, before step (b) of extraction.

[0122] For the purposes of this invention, "frozen" means a plant which, prior to step (b) of extraction, has undergone a freezing step, and therefore a plant which has been kept at a temperature below 0°C, preferably below -5°C, in particular below -10°C, or even below -15°C, preferably for at least 2 hours, in particular at least 5 hours, and better for a period of between 2 hours and 7 days, in particular between 5 hours and 5 days, better between 8 hours and 3 days, and especially between 12 hours and 1 day.

[0123] According to a first embodiment, a method of obtaining according to the invention does not include, in particular before step (b), a step of freezing, drying, dehydration, freeze-drying, grinding, decoction, enfleurage, infusion, addition of solvent(s), Soxhlet extraction, sonication-assisted extraction, supercritical fluid extraction, extraction based on the principle of sonoporation, and / or ultrasonic disintegration, and combinations thereof, of the plant or part of the plant of interest obtained in step (a).

[0124] According to another embodiment, a method of obtaining according to the invention may further comprise, in particular before step (b), at least one step of freezing, drying, dehydration, freeze-drying, grinding, decoction, enfleurage, infusion, addition of solvent(s), Soxhlet extraction, sonication-assisted extraction, supercritical fluid extraction, extraction based on the principle of sonoporation, and / or ultrasonic disintegration, and combinations thereof, of the plant or part of the plant of interest obtained in step (a).

[0125] According to a preferred embodiment, a method for obtaining the product according to the invention may advantageously include, before step (b):

[0126] - a freezing step of the plant or the part of the plant of interest. This variant is particularly advantageous when the extraction step is carried out in its native water; and / or

[0127] - a step of grinding the plant or the part of the plant of interest.

[0128] Preferably, a method of obtaining according to the invention, prior to step (b), does not include a step of grinding the plant or the part of the plant of interest.

[0129] As previously stated, extraction step (b) is based on at least one extraction cycle, preferably comprising at least two successive different extraction steps (b1) and (b2), and preferably carried out within the same extraction device, or even the same receptacle, namely:

[0130] - a microwave extraction step, the product obtained from this first microwave extraction being referred to as the "first extract"; and / or

[0131] - a maceration extraction step applied to the plant or plant part of step (a) or to the first extract obtained in step (b1) (where present), the product obtained from this maceration extraction being able to be designated interchangeably as "extract of interest", "second extract" or "final extract".

[0132] Step (b1) and / or step (b2) may be carried out without the addition of extraction solvent or is / are carried out in the presence of at least one extraction solvent, identical or different, and preferably chosen from water, at least one alcohol, a hydro-alcoholic solvent, and mixtures thereof, and particularly chosen from glycerin, water, ethanol, isopropanol, propanediol, butylene glycol, and mixtures thereof.

[0133] Preferably, extraction step (b), and in particular step (b1) and / or (b2), is / are carried out without the addition of any extraction solvent, using the plant's native water. In other words, no extraction solvent is used to carry out step (b), and in particular step (b1), and the extraction solvent used to carry out step (b2) is the native water extracted from the plant during step (b1).

[0134] Thus, the microwave extraction step (b1) is in this variant of the embodiment carried out without the addition of extraction solvent, using only native water, namely water that is an integral part of the plant from the beginning, and in particular water that is an integral part of the plant cells.

[0135] According to a particular embodiment, an extraction process according to the invention may comprise several extraction cycles, identical or different, in particular with respect to the power of the microwave extraction, the duration of step (b1) and / or (b2) and / or the respective sequences in step(s) (b1) and / or (b2), as described in more detail below.

[0136] Step (b1) - first microwave extraction step

[0137] The microwave extraction step can be referred to interchangeably as the "microwave radiation extraction step", and is carried out using a microwave radiation heat treatment device.

[0138] Such microwave heating technology is particularly suitable for plants because it allows direct heating to the core of the material for thin layers up to the order of a centimeter.

[0139] The microwave extraction device comprises at least one tank and at least one microwave generator with a frequency ranging, for example, but not limited to, between 300 MHz and 6000 MHz, and preferably around the standard frequencies of 2450 MHz or 915 MHz. This generator is connected, via at least one waveguide and flanges, to an enclosure. The purpose of the microwave generator(s) is / are to provide the energy necessary for the thermal treatment of the material being treated. Other heat sources may be added to increase the treatment efficiency, such as, for example, hot air or infrared radiation. The enclosure may have dimensions ranging, for example, but not limited to, between 300 mm and 2500 mm. One or more air inlet ports may be placed on the waveguides to allow, for example, dust removal or cooling.The flanges connecting the waveguide to the inlet waveguide can be equipped with a quick-release locking / unlocking system, for example, but not limited to, using compressed air. At least one window, for example, made of quartz or any other equivalent microwave-transparent material, can also be placed between the flanges to prevent dust from being drawn into the waveguide during heating cycles. In one embodiment, the enclosure is mounted to pivot, for example, on a base by means of an axis passing, for example, through the center of gravity of the enclosure. Pivoting means, such as a geared motor assembly, can allow the enclosure to be rotated rapidly about its axis. Such a device is described in particular in EP2530059.

[0140] In particular, the microwave extraction device includes a tilting rotating tank with ultrasound at the bottom of the tank.

[0141] Preferably, step (b1) of microwave extraction can be carried out:

[0142] - at a power rating between 300 W and 6000 W, preferably between 600 W and 5000 W, better between 800 W and 4000 W, and particularly between 1000 W and 2000 W, or even between 300 W and 1000 W (W = Watts); and / or

[0143] - for a period of between 1 minute and 180 minutes, preferably between 2 minutes and 120 minutes, better between 5 minutes and 100 minutes, especially between 10 minutes and 60 minutes, or even between 15 minutes and 30 minutes.

[0144] Preferably, step (b1) of microwave extraction can be carried out at a temperature between 30°C and 120°C, preferably between 40°C and 100°C, and better between 50°C and 90°C, preferably between 60°C and 80°C, and especially between 65°C and 75°C.

[0145] Preferably, the microwave extraction device may also include at least:

[0146] - a solution for mixing the plant to be treated; and / or

[0147] - a rotating tank forming a cavity preferably made of a refractory metal with low resistivity, driven in rotation by means allowing its speed to be varied in order to optimize the mixing of the plant being treated. Such an embodiment is described in particular in EP2530059.

[0148] Such embodiments are advantageous because they allow heat exchange between particles by convection, conduction, and, at higher temperatures, by radiation. This continuous exchange enables precise temperature balancing of the particles at every instant.

[0149] Advantageously, the microwave extraction step can be carried out via flash heat treatment, as described in FR2976062.

[0150] Advantageously, the microwave extraction device may also include conventional means for performing partial or total vacuum extraction. Preferably, the partial vacuum may advantageously be between 50 mb and 300 mb. In a single extraction cycle, the microwave extraction step (b1) may comprise one or more identical or different microwave treatment sequences, particularly with respect to their power, temperature, and / or duration.

[0151] According to a particular embodiment, the device used for the microwave extraction step is the one marketed under the names E200 to TE2000, ECT200 to ECT1000 or ECS150 to ECS1000, by IDCO, or the one marketed under the name EMU06 by SAIREM. In particular, a device for the microwave extraction step is TE200 marketed by IDCO.

[0152] A person skilled in the art will be able to adjust / adapt the device if necessary, especially when microwave extraction is carried out in native water, i.e. without the addition of extraction solvent.

[0153] Step (b2) - second maceration extraction step

[0154] According to a first preferred embodiment, the maceration extraction step is carried out without the addition of an extraction solvent, using only the first extract. Thus, the extraction solvent considered for this maceration extraction step is the first extract obtained at the end of step (b1).

[0155] According to a second embodiment, the extraction step (b2) can be carried out in the presence of at least one extraction solvent. When both steps (b1) and (b2) use at least one extraction solvent, this solvent may be the same or different. Naturally, those skilled in the art will ensure that the extraction solvent(s) and / or their quantity are chosen in steps (b1) and / or (b2) in such a way that the advantageous properties of a process according to the invention, and in particular of the extract according to the invention, are not, or are not substantially, altered by the intended addition. Also, those skilled in the art will ensure that the nature and / or quantity of the extraction solvent(s) are chosen according to the molecule(s) or active agent(s) to be extracted.

[0156] For illustrative purposes, an extraction solvent usable in step (b1) and / or in step (b2) may be chosen from water, at least one alcohol, a hydro-alcoholic solvent, and mixtures thereof, and particularly chosen from glycerin, water, ethanol, isopropanol, propanediol, butylene glycol, pentylene glycol, propylene glycol, and mixtures thereof.

[0157] Preferably, maceration extraction step (b2) can be carried out for a duration of between 1 minute and 300 minutes (or 5 hours), in particular between 5 minutes and 300 minutes (or 5 hours), preferably between 10 minutes and 240 minutes (or 4 hours), better between 10 minutes and 180 minutes (or 3 hours), especially between 1 hour and 120 minutes (or 2 hours), or even between 10 minutes and 40 minutes. In the same extraction cycle, maceration extraction step (b2) may include one or more maceration treatment sequences, identical or different, in particular with regard to temperature, nature and / or quantity of extraction solvent(s), and / or duration.

[0158] According to a first preferred variant, the maceration extraction step (b2) is carried out at room temperature, preferably at a temperature between 15°C and 30°C, preferably between 18°C ​​and 27°C, and particularly between 20°C and 25°C.

[0159] According to another variant, step (b2) of extraction by maceration is carried out cold.

[0160] When step (b) includes step (b1) and step (b2), step (b2) of maceration extraction is advantageously carried out with, and within, the same device as that used for step (b1) of microwave extraction.

[0161] Preferably, the maceration extraction device may also include at least:

[0162] - a solution for mixing the plant to be treated; and / or

[0163] - a rotating tank forming a cavity preferably made of a refractory metal with low resistivity, driven in rotation by means allowing its speed to be varied in order to optimize the mixing of the plant being treated. Such an embodiment is described in particular in EP2530059.

[0164] Additional step(s)

[0165] According to a particular embodiment, the process for obtaining the product according to the invention may further comprise, during step (b1), between steps (b1) and (b2), and / or after step (b2), at least one cooling step (g). This cooling step may be carried out such that the first extract and / or the extract of interest is discharged by tipping into a cooler, for example, with air, the airflow of which is ensured, for example, by a fan. One purpose of this cooler is to accelerate the cooling of the material. Another purpose of this cooler is to recover the heat emitted by the processed material after its removal from the chamber, during the cooling step. The cooling of the processed material may, for example, be carried out by circulating an airflow over it, for example, by means of a fan or any other equivalent means.

[0166] In one particular embodiment, the extraction process includes at least one cooling step (g) carried out simultaneously with step (b1), and possibly also with step (b2), in the tank (or receptacle) containing the plant. In this embodiment, the tank of the device is advantageously equipped with a double jacket, with cooling occurring in the outer jacket. This embodiment is advantageous because it allows, in particular, the condensation of volatile matter extracted during step (b1), and thus optimizes the composition and / or the extraction yield of the first extract, and therefore of the extract of interest.

[0167] According to another particular embodiment, a method for obtaining the product according to the invention may further comprise, before step (b), between steps (b1) and (b2), and / or after step (b2), and preferably after step (b2), at least one additional solid / liquid separation step (e), in particular a pressing or centrifugation step. This solid / liquid separation step (e), carried out on the plant, the first extract, and / or the extract of interest, and preferably on the extract of interest, may be carried out using any suitable device, and in particular using a press.

[0168] According to another particular embodiment, an extraction process according to the invention may further comprise, after step (b), and in particular after step (b2), at least one additional filtration step (c). This filtration, carried out on the extract of interest, may be performed using any suitable device, in particular a sieve or a filter. Advantageously, the filtration allows the "juice" (or "filtrate") of the extract of interest to be separated from any fibers and other solid plant elements larger than the pores of the filter device. Preferably, this filtration operation removes from the extract of interest any element larger than 0.2 microns (µm), which corresponds to the debacterial threshold. Preferably, filtration step (c) is carried out using a plate filter, which allows filtration to be reduced, preferably down to 0.2 microns, by a cascade of steps.

[0169] Advantageously, a method of obtaining according to the invention comprises after step (b), and preferably after step (b2), at least one solid / liquid separation step (e), in particular by pressing or centrifugation, and / or at least one filtration step (c).

[0170] According to yet another particular embodiment, an extraction process according to the invention may further comprise, after step (b), and in particular after step (b2), at least one additional step (d) of mixing the extract, where appropriate obtained at the end of step (e) or (c) described above, with at least one solvent, in particular a preservation solvent.

[0171] Preferably, a preservative solvent can be chosen from glycerin, propanediol (or propylene glycol), butylene glycol, pentylene glycol, and mixtures thereof, and preferably glycerin. This step (d) is advantageous in that it prevents bacterial growth, thus improving the preservation of the product obtained from the extraction process according to the invention. Preferably, the extract of interest is mixed with at least one preservative solvent in an "extract of interest / preservation phase" ratio of between 10 / 90 and 95 / 5, preferably between 10 / 90 and 60 / 40, better between 20 / 80 and 50 / 50, and in particular between 20 / 80 and 40 / 60.

[0172] Preferably, a process according to the invention may further comprise at least one step (f) of decolorizing the extract. The decolorization may be carried out by adsorption of any pigments present in the extract or filtrate onto activated carbon under stirring for a period of 1 to 6 hours, preferably 2 to 4 hours, at room temperature. Preferably, the activated carbon represents 30% by mass relative to the dry matter of the extract. This decolorization step may be followed by a filtration step of the resulting decolorized filtrate, for example, by passing it through a 4 µm sieve or filtration membrane.

[0173] Preferably, when step (b) is carried out in the presence of at least one aqueous, alcoholic, or hydroalcoholic solvent, a process according to the invention may further comprise, between steps (b) and (d), or even between steps (c) and (d), at least one solvent removal step (h), preferably by evaporation. Preferably, this step (h) is carried out by partial or total evaporation under reduced pressure, for example, using a rotary evaporator or a scraped-film evaporator. This step (h) is particularly advantageous in that it allows the extract according to the invention to be concentrated while ensuring the absence of hazardous and / or polluting solvents, even in trace amounts.

[0174] Advantageously, a method of obtaining it according to the invention:

[0175] - does not include, before step (b), a step of adding solvent(s), in particular hydrophilic (or aqueous) and / or lipophilic and / or amphiphilic solvent(s);

[0176] - does not include an oil addition step;

[0177] - does not include a step of contact with supercritical CO2;

[0178] - does not include a separation step between an oil phase and an aqueous phase; and / or

[0179] - does not include a heating step under an atmosphere devoid of, or essentially devoid of, C>2.

[0180] Extract

[0181] For the purposes of this invention, the extract comprises at least one active agent. For the purposes of this invention, "active agent" means a compound having a beneficial physiological effect on the element on which it acts. Its purpose may be, for example, to protect, maintain, treat, cure, perfume, flavor, or color. The extract of interest is advantageously a cosmetic, dermo-pharmaceutical, pharmaceutical, or food-grade agent.

[0182] Preferably, an active agent is chosen from polyphenols, proteins, amino acids, peptides, sugars, minerals, vitamins, carotenoids, enzymes, niacinamide, and mixtures thereof.

[0183] Preferably, an active agent is niacinamide. Niacinamide is a water-soluble vitamin. Niacinamide is the precursor of two important molecules: nicotinamide adenine dinucleotide (NAD+) and its phosphate derivative (NADP+), which are the main cofactors of redox reactions in cells.

[0184] Redox reactions, which are processes involving the transfer of electrons, are central to basic life functions, including metabolism and respiration, so almost all cellular metabolic pathways require them. Due to its role as a precursor, niacinamide indirectly exerts multiple effects on the skin.

[0185] An extract according to the invention is particularly advantageous with regard to its optimized niacinamide content, as previously stated.

[0186] Composition

[0187] Preferably, the extract according to the invention (or "extract of interest") can be used in the fields of cosmetics, nutraceuticals, food, or pharmaceuticals.

[0188] Thus, an extract of interest can be implemented in a composition, in particular a cosmetic, pharmaceutical, nutraceutical or food composition, optionally in association with at least one physiologically acceptable medium.

[0189] Preferably, the composition according to the invention may comprise between 0.01% and 20%, preferably between 0.1% and 10%, better between 0.5% and 5%, and most particularly between 1% and 3%, by weight of extract(s), relative to the total weight of the composition.

[0190] A composition according to the invention can in particular be adapted for application by oral route or by topical route, preferably topical.

[0191] Preferably, a composition according to the invention is a cosmetic composition, in particular dedicated to the care and / or makeup of a keratinous material, and in particular of the skin and / or hair.

[0192] In particular, the composition of the invention may be in the form of an anti-aging skincare composition, especially for the face. According to another embodiment, a composition of the invention may be in the form of a makeup composition, especially in the form of a foundation, a tinted base or a tinted cream.

[0193] A composition according to the invention may further comprise at least one physiologically acceptable medium (or solvent), chosen in particular according to the different ingredients, the form of administration and / or the cosmetic, pharmaceutical, nutraceutical or food purpose.

[0194] In the context of the invention, and unless otherwise stated, "physiologically acceptable medium" means a medium suitable for the application considered, in particular for cosmetic applications, and suitable in particular for the application of a composition according to the invention on a keratinous material, in particular the skin and / or hair, and more particularly the skin.

[0195] The physiologically acceptable medium is generally adapted to the nature of the support on which the composition is to be applied, as well as to the appearance in which the composition is to be packaged.

[0196] When the application in question is a cosmetic application, the physiologically acceptable environment is particularly compatible with the skin, mucous membranes and hair.

[0197] Examples include water (preferably demineralized water or floral waters), optionally in combination with at least one preservative and / or alcohol.

[0198] A composition comprising at least one extract according to the invention may be in any form. Such a composition may be, for example, a cream, an emulsion (direct, inverse or multiple), a lotion, a serum, a gel and an oil for the skin (hands, face, feet, etc.), a foundation (liquid, paste), a preparation for baths and showers (salts, foams, oils, gels, etc.), a hair care product (hair dyes and bleaches), a cleaning product (lotions, powders, shampoos), a hair conditioning product (lotions, creams, oils), a styling product (lotions, hairsprays, brilliantines), a shaving product (soaps, foams, lotions, etc.), a product intended to be applied to the lips, a sunscreen, a sunless tanning product, a skin whitening product, an anti-wrinkle product.In particular, a cosmetic composition can be an anti-aging serum, a youth serum, a hydrating serum or a perfumed water.

[0199] A food composition comprising at least one extract according to the invention may be, for example, a yogurt or a food supplement, in particular a liquid one. Additional compound(s)

[0200] An extract, or even a composition comprising at least said extract, according to the invention, may further comprise at least one additional compound different from the aforementioned extract and physiologically acceptable medium.

[0201] An extract, or even a composition, according to the invention, may further comprise at least powders, organic or inorganic; hydrophilic texturizing agents (or hydrophilic gelling agents), in particular as described in FR3041251; film-forming agents; coloring agents, in particular selected from water-soluble or insoluble, fat-soluble or insoluble, organic or inorganic coloring agents, optical effect materials, liquid crystals, and mixtures thereof; fillers, in particular pigments and / or pearlescent pigments, in particular as described in FR3067930 and / or blurring / soft-focus fillers, in particular as described in WO2019053236; fillers such as lauroyl-lysine, starch, boron nitride and / or silica; emulsifying and / or non-emulsifying silicone elastomers, in particular as described in EP2353577; texturizing agents; surfactants; glycerin; preservatives; salts;humectants; stabilizers; pH stabilizing agents, in particular a pH buffer (e.g., HEPES, PBS); chelating agents; oils; emollients; retarding agents; etc... or any common cosmetic additive; and mixtures thereof.

[0202] An extract, or even a composition, according to the invention, may further comprise at least one biological / cosmetic active ingredient (or active agent) different from the extract of interest. The active agent is advantageously a cosmetic, dermo-pharmaceutical, pharmaceutical, or food-grade agent.

[0203] A biological / cosmetic active ingredient can be chosen from among moisturizing agents, healing agents, depigmenting agents, UV filters, desquamating agents, antioxidant agents, active ingredients stimulating the synthesis of dermal and / or epidermal macromolecular molecules, dermo-contracting agents, anti-perspirant agents, soothing agents, anti-wrinkle agents, anti-irritant agents, tightening / smoothing agents, anti-cellulite agents, firming agents, sheathing agents, softening agents, emollient agents, slimming agents, protective / anti-radical agents, draining agents, anti-inflammatory agents, whitening agents, self-tanning agents, vitamins, exfoliating agents, agents stimulating cell renewal or stimulating cutaneous microcirculation, absorbing agents, anti-dandruff agents and / or anti-aging agents, and their mixtures.

[0204] When the active agent is a pharmaceutical agent, it is advantageously chosen from among anticoagulants, antithrombogenics, antimitotic agents, antiproliferative agents, antiadhesion, antimigration agents, cell adhesion promoters, growth factors, antiparasitic molecules, anti-inflammatories, angiogenics, angiogenesis inhibitors, hormones, proteins, antifungals, antimicrobial molecules, antiseptics, antibiotics, and mixtures thereof.

[0205] The food-grade agents are advantageously vegetable or fruit purees such as mango puree, pear puree, coconut puree, cream of onions, leeks, carrots, or other preparations that can combine several fruits or vegetables. Alternatively, they are oils such as edible oils, like olive oil, soybean oil, grapeseed oil, sunflower oil, or any other oil extracted from plants, as well as food-grade active ingredients such as probiotics, yeasts, vitamins, minerals, oleoactives, and mixtures thereof.

[0206] An extract, or even a composition, according to the invention, may further comprise excipients, such as thickeners, or rheology modifiers. These thickeners are, for example, polymers, cross-polymers, microgels, gums or proteins, including polysaccharides, celluloses, polysaccharides, silicone-based polymers and copolymers, colloidal particles (silica, clays, latex, etc.), and mixtures thereof.

[0207] The additional compound(s), in particular the active ingredient(s), may be hydrophilic or lipophilic.

[0208] Naturally, a person skilled in the art will take care to choose any additional compound(s) and / or their quantity in such a way that the advantageous properties of a composition according to the invention, and in particular of the extract according to the invention, are not or substantially not altered by the proposed addition. These adjustments fall within the general knowledge of a person skilled in the art.

[0209] Preferably, a composition according to the invention is free of surfactant.

[0210] Uses

[0211] According to another aspect, the invention relates to the non-therapeutic use, particularly cosmetic, of an extract according to the invention, to prevent and / or combat skin aging, in particular photo-induced skin aging, improve cell longevity, restore the skin barrier function and / or improve skin hydration.

[0212] For the purposes of this invention, "cosmetic" means a non-pharmaceutical, non-therapeutic use, not intended for therapeutic use, nor to prevent or treat symptoms related to a therapeutic skin condition. Indeed, advantageously, the Applicant has found that an extract according to the invention possesses several activities of interest with regard to preventive or repairing physiological mechanisms related to the skin barrier function, hydration and / or skin cell longevity.

[0213] As can be seen from the examples below, the Applicant notably found, advantageously and unexpectedly, that an extract according to the invention made it possible to stimulate biological pathways related to the skin barrier function and in particular markers of skin aging, such as ceramides, the expression of the hyaluronan synthase 2 (HAS2) enzyme, the expression of the superoxide dismutase 1 (SOD1) enzyme, the visibility of pores and skin imperfections, and skin hydration.

[0214] According to a particular embodiment, the extract according to the invention is used to reduce the oily appearance of the skin, regulate sebum production, limit lipid accumulation in sebocytes, reduce the visibility of pores and / or reduce skin imperfections.

[0215] According to another particular embodiment, the extract according to the invention is used to promote epidermal renewal, improve skin texture and / or enhance the radiance of the complexion.

[0216] According to yet another particular embodiment, the extract according to the invention is used to stimulate the synthesis of pro-collagen I, limit the decrease in pro-collagen I synthesis induced by UV exposure, prevent and / or combat photo-induced skin aging, improve skin firmness and / or prevent or reduce skin laxity.

[0217] According to yet another particular embodiment, the extract according to the invention is used to increase the intracellular level of NAD + in skin cells, particularly in dermal fibroblasts, and / or to support energy metabolism and redox defense mechanisms of skin cells.

[0218] Throughout the description, including the claims, the expression "comprising one" shall be understood as synonymous with "comprising at least one", unless otherwise specified.

[0219] The expressions "between ... and ...", "from ... to ..." and "ranging from ... to ..." should be understood inclusive of boundaries, unless otherwise specified.

[0220] The following examples illustrate the present invention without limiting its scope. Unless otherwise stated, the quantities of ingredients shown in the examples are expressed as a percentage by weight of the total weight of the composition. EXAMPLES

[0221] Example 1 - cultivation of Pisum sativum

[0222] This example 1 relates to steps (a) and (b) of a process for obtaining at least one pea extract according to the invention.

[0223] The objective is to determine growing conditions that allow for maximum niacinamide concentration in the biomass while maintaining an acceptable total yield.

[0224] The plant seeds of the species Pisum sativum used are of the pea variety "Dwarf grey sugar pea for shoots" supplied by the company Johnny selected seeds.

[0225] Before being planted in a tray (or Trayplant), which consists of individual pots or cells grouped on a tray, the seeds undergo a 24-hour soaking period at room temperature. The seeds are then grown hydroponically using a hemp substrate.

[0226] Example 1 focused on the effect of exposure to UV radiation during the growth phase, in order to cause oxidative stress and thus induce an increase in niacinamide content in the plant.

[0227] The parameters tested were the light source (i.e. white light with or without UVB), the duration of UV exposure per day, the post-exposure U growth time before harvest, and the harvest stage (duration of the culture cycle).

[0228] Table 1 below summarizes the parameters and growing conditions considered.

[0229] [Table 1]

[0230] Duration of post-culture duration of cycle

[0231] Photo for display at exhibitions (or recovery) Culture Trial®

[0232] UV period® per day® (5)

[0233] (in days)

[0234] (in hours) (in days)

[0235] 1 12 18 / 6® - - 2 9 18 / 6 - - 3 12 18 / 6 12 1

[0236] 4 12 18 / 6 16® 3

[0237] 5 12 18 / 6 12 3

[0238] 6 12 18 / 6 16 1

[0239]

[0240] (1) Total illumination time (i.e. visible light + UV light (when added).

[0241] (2) Duration of lighting during the associated photoperiod combining visible light and UV light, with a broad UV spectrum, namely a continuous spectrum between 300 and 350 nm with a max in the UVB at 310 nm, using the Migrolight UVB / A device.(3) "18 / 6" means that, over 24 hours, the cultivated plants are lit for 18 hours and then left in darkness for 6 hours.

[0242] (4) "16" means that, out of 18 hours of lighting, 16 hours were under lighting combining visible light and UV light.

[0243] (5) Recovery time before harvest, i.e. the number of day(s) before harvest during which all UV light illumination has been stopped.

[0244] (6) To avoid any ambiguity, the duration of the culture cycle includes the germination phase.

[0245] For each trial, approximately 300 grams of frozen plant material at -20°C are used to perform the extraction, without the addition of solvent.

[0246] Each aqueous extraction process implemented is based on an extraction cycle comprising:

[0247] (b1) a first microwave-assisted extraction step carried out at 300W for 10 minutes with the IDCO E200 machine; and

[0248] (b2) a second extraction step by maceration for 10 minutes applied to the first aqueous extract obtained in step (b1) and in the same container as that used in step (b1).

[0249] The extracts thus produced are then analyzed by UPLC-DAD chromatography, the implementation of which relies on the general knowledge of a person skilled in the art. The samples to be analyzed are dissolved at the desired concentrations in an extraction solvent containing a mixture of water and isopropanol and then filtered through a 0.2 µm filter. They are then eluted using a C18-type column in isocratic mode with acidified water. The peak areas obtained are then compared with a calibration curve prepared using a niacinamide standard. The results are calculated by calibration using dedicated processing software to obtain a result expressed in g per 100 g (%).

[0250] Results :

[0251] The results obtained are presented in Table 2 and Figures 1 to 3 below.

[0252] [Table 2]

[0253] Niacinamide (mg / g) DW % by weight of extract Niacinamide assay (in gg / g)

[0254] dry

[0255] 1 80 2.16 0.216

[0256] 2148 3.21 0.321

[0257]

[0258] 3182 3.74 0.374

[0259] 4194 4.41 0.441

[0260] 5,201 4.73 0.473

[0261] 6,208 4.59 0.459

[0262]

[0263] Table 2 and Figures 1 to 3 show the impact of normal light and UV light lighting, under different growing conditions, on niacinamide content and production yields.

[0264] [Fig. 1] Figure 1 shows that UV illumination induces a significant increase in niacinamide content. Indeed, after exposure to the Migrolight UVB UV source, the tested variety (i.e., trial 6) produces approximately 3 times more niacinamide than the one not exposed to UV (i.e., trial 1).

[0265] [Fig. 2] Figure 2 shows that exposure to different light sources, including a UV source, has a relatively small detrimental effect (i.e., < 16%) on production yields. This result is surprising given the morphological changes in plants induced by UVB radiation.

[0266] [Fig. 3] Figure 3 shows that UV lighting induces a significant increase in niacinamide content per unit area of ​​cultivated soil. Indeed, after exposure to the Migrolight UVB UV source, the tested plant (i.e., trials 4, 5, and 6) produces significantly more niacinamide than the plant not exposed to UV (i.e., trials 1 and 2).

[0267] Figure 3 also shows that the maximum niacinamide yield is unexpectedly directly correlated with the "recovery time" following the duration of UV light exposure, i.e., the time between the cessation of UV light exposure and harvest. Thus, Figure 3 shows that the maximum niacinamide yield is achieved with 18 hours of lighting per day, including 12 hours of UV light exposure per day, and a cessation of exposure 3 days before harvest (i.e., trial 5). This "recovery" time appears essential to allow plants to resume biomass growth after the stress generated by UV exposure, likely by increasing niacinamide production in response to UV stress.

[0268] The invention is therefore based on the identification of a particularly interesting and advantageous compromise between (i) plant stress by UV lighting and (ii) biomass yield.

[0269] Integrating the results from Example 1 led to the development of an optimized cultivation method for niacinamide production in pea microgreens. Compared to the standard pea microgreen cultivation method, which is not exposed to UV light, the cultivation method described in Experiment 5 resulted in a 151% increase in niacinamide concentration in the biomass. Considering the biomass yield and the five-level layering made possible by vertical cultivation, niacinamide production can thus be increased from 391 g / m². 2 at 3405 g / m 2 , which is a production multiplied by 8.7.

[0270] Example 2 - Objectification and characterization of the cosmetic effects of a pea extract according to the invention

[0271] Human skin is an organ structured in distinct layers: the epidermis (outermost layer), the dermis (middle layer), and the hypodermis (innermost layer). The outermost part of the epidermis, called the stratum corneum (CC), the skin's main barrier structure, is composed of terminally differentiated keratinocytes held together by lipids. These lipids act as structural support, a natural water repellent inhibiting excessive water loss through transcutaneous evaporation (TEWL), and a barrier to the entry of chemicals and microorganisms: the lipid barrier. Ceramides represent approximately 50% of the skin's lipid content.

[0272] Skin aging is characterized by a decrease in the structural integrity and physiological functions of all skin layers, and in particular a general decline in the condition of the dermis. The dermis is composed of a fibroelastic matrix (or fibrous matrix) including collagen bundles, which contribute to the skin's tensile strength, and glycosaminoglycans (GAGs), long linear chains of polysaccharides that play an important role in retaining water in the skin. Among the GAGs, hyaluronic acid (HA) is the most important, as it has the capacity to retain water molecules up to 1000 times its molecular weight. In the dermis, it is cross-linked to other matrix proteins such as collagen, forming a dense structure that increases skin rigidity. The structure of the fibroelastic matrix deteriorates with age.Fibroblasts lose their ability to proliferate and synthesize collagen. Furthermore, several enzymes responsible for collagen fragmentation increase, leading to an overall decrease in collagen within the matrix. Hyaluronic acid (HA) levels also decline, primarily due to decreased expression of hyaluronan synthase 2 (HAS2). Consequently, the skin's dermis gradually becomes thinner and more uneven. Wrinkles appear, and pores lose their definition and become more prominent.

[0273] During aging, almost all processes leading to dermal degradation involve a common cellular mechanism: the loss of defense against oxidative stress. To counteract the harmful accumulation of reactive oxygen species (ROS), the skin has defense mechanisms including antioxidant and detoxification systems that diminish, or even disappear, with age. The enzyme superoxide dismutase 1 (SOD1) notably functions to dismutate the superoxide anion, one of the toxic byproducts of mitochondrial respiration.

[0274] Example 3 involves studying the effects of the pea extract obtained in trial 5 of example 1, in order to observe its impact on the ceramide level, the expression of the hyaluronan synthase 2 (HAS2) enzyme and the expression of the superoxide dismutase 1 (SOD1) enzyme, known to be biomarkers used to assess skin barrier function, skin laxity, particularly related to age, and skin hydration.

[0275] 2.1) Procedure on HaCaT keratinocytes, representative of the epidermis:

[0276] 2.1.1) Effects on ceramides (CER)

[0277] The study was performed on HaCaT keratinocytes, representative of the human epidermis. The cells were then seeded onto 60 mm diameter Falcon® cell culture dishes (10 6cells / culture dishes). The cells were able to attach to the cell culture plastic by incubation overnight at 37°C and 5% CO2. Subsequently, the HaCaT keratinocytes were treated with or without different doses of pea extract for 48 hours. The cells were then rinsed, lysed, and the proteins extracted for quantification by ELISA.

[0278] [Fig. 4] Figure 4A illustrates a standard ceramide (CER) curve. This is a nonlinear regression model of absorbance values ​​obtained from serial dilutions of the CER standard, provided by the manufacturer of the ELISA kit used in the study (MyBiosource, MBS7254089). Figure 4B illustrates a bar chart representing intracellular ceramide levels after 48 hours of treatment of human HaCaT keratinocytes with PEA064 at 0.1%, 1%, and 3%. Asterisks (*) above the bars indicate statistical significance (one-way ordinary ANOVA followed by Dunnett's multiple comparisons test).

[0279] The ELISA test revealed a statistically significant overall increase in intracellular ceramides in HaCaT keratinocytes exposed to all tested doses of pea extract. Specifically, ceramides increased significantly by 44.4%, 44.8%, and 44.2% at 0.1%, 1%, and 3% pea extract, respectively, compared to the untreated control. 2.1.3) Effects on HAS2 and SOD1

[0280] The study was performed on NH DF fibroblasts. The fibroblasts were seeded (10 4 cells / wells (or “cells / well”)) and treated with or without pea extract for 24 hours. The cells were then rinsed and the RNA extracted, then transcribed by inversion into complementary DNA and the relative expression of the HAS2 and SOD1 genes was assessed by quantitative polymerase chain reaction (qPCR).

[0281] [Fig. 5] [Fig. 6] Figures 5 and 6 illustrate bar charts representing HAS2 and SOD1 levels, respectively, relative to the control. Asterisks (*) above the bars indicate a statistically significant result compared to the control (ANOVA followed by Dunnett's multiple comparison test).

[0282] The qPCR test revealed that NH DF keratinocytes exposed to pea extract underwent a dose-dependent increase in HAS2 gene expression which reached statistical significance for the 3% dose, representing a 204.3% increase compared to the untreated control.

[0283] Regarding antioxidant activity, pea extract triggered a statistically significant increase in SOD1 expression from 24.8% and 31.0% to 0.3% and 3%, respectively, compared to the untreated control.

[0284] Example 3 demonstrates the moisturizing and antioxidant effects of a pea extract according to the invention.

[0285] 2.2) Clinical study

[0286] The objective of the study is to evaluate the quality of the skin after treatment with a cream containing 3% of pea extract according to trial 5 of example 1.

[0287] The composition of the cream is described in Table 3 below.

[0288] [Table 3]

[0289] Raw material INCI

[0290] % w / w Phase Continuous aqueous phase Total 100.00

[0291] ROTO WATER AQUA QSP* NATRLQUEST E30 AQUA, TRISODIUM

[0292] ETHYLENEDIAMINE DISUCCINATE 0.18 MICROCARE EMOLLIENT PTG PENTYLENE GLYCOL, AQUA 3.62 ZEMEA SELECT PROPANEDIOL PROPANEDIOL, AQUA 4.83 NIPAGUARD CP CHLORPHENESIN 0.33 RHODICARE T - (OUVRICARE T) XANTHAN GUM, AQUA 0.24

[0293]

[0294] CARBOPOL ULTREZ 10 POLYMER CARBOMER 0.24GLYCERIN 4811 [MB] GLYCERIN, AQUA 1.93 PEA EXTRACT / 3.62 RONACARE SODIUM HYDROXIDE AQUA, SODIUM HYDROXIDE 0.10

[0295] Dispersed fatty phase Total 100.00 MONTANOV 68 MB / 17.49 LIPEX SMP [MB] HYDROGENATED VEGETABLE

[0296] OIL 17.49 MOD MB OCTYLDODECYL MYRISTATE,

[0297] AQUA QSP DUB 810 C / MB - COCO-CAPRYLATE / CAPRATE, COPRAH CAPRYLATE / CAPRATE AQUA 23.32 KF-96A-50CS / DM-FLUID-50CS DIMETHICONE 11.66

[0298]

[0299] * QSP: Quantity Sufficient For

[0300] The preparation of the phases and the emulsion falls within the general knowledge of a person skilled in the art. The "continuous aqueous phase / dispersed oil phase" mixture is prepared in an 80:20 ratio.

[0301] The effects on pores (surface area, perimeter, number, etc.) and skin hydration were then evaluated using the following instrumental techniques:

[0302] • 3D topographic analysis using the AEVA-HE V4 system (FoV, S) to assess pores in the nose and cheek area; and

[0303] • Analysis of cheek skin hydration level measurement using the Corneometer CM 825 system.

[0304] Instrumental measurements were performed before the start of treatment (D0), after 4 weeks of treatment (D28) and after 8 weeks of treatment (D56).

[0305] The following protocol was used:

[0306] 33 volunteers with very dry or dry skin type and large pores (grades 2 to 4, Eiben-Nielson photonumerical scale for pores)

[0307] Age: 29-55 (average 40.9 ± 7.0)

[0308] Application: Entire face, twice a day (morning and evening).

[0309] 2.2.1) Results of the 3D topographic analysis

[0310] [Fig. 7] Figure 7 shows that the application of a cream containing 3% pea extract significantly reduced the number, surface area, perimeter, and volume of facial pores after 8 weeks of treatment (Day 56) by 8.5%, 10.1%, 9.2%, and 10.9%, respectively, compared to the start of treatment (Day 0). These results were confirmed by 3D HD macroscopic images obtained at different time points, which showed an overall reduction in the visibility of pores and skin imperfections (not shown). 2.2.2) Corneometer Analysis Results

[0311] [Fig. 8] Figure 8 indicates that the application of a cream containing 3% pea extract induces a statistically significant improvement in skin hydration of 38.9% after 4 weeks of treatment (D28) and 41.5% after 8 weeks (D56), compared to the baseline before the start of treatment (D0).

[0312] CONCLUSIONS:

[0313] The results above show that a pea extract according to the invention induces:

[0314] - an increase in ceramides;

[0315] - an increase in the expression of the hyaluronan synthase 2 (HAS2) enzyme;

[0316] - an increase in the expression of the superoxide dismutase 1 (SOD1) enzyme; - an overall reduction in the visibility of pores and skin imperfections; and - a statistically significant improvement in skin hydration.

[0317] Therefore, these results demonstrate that a pea extract according to the invention can effectively prevent and / or combat skin aging, restore the skin's barrier function, improve skin hydration, and reduce the visibility of pores.

[0318] Example 3 - Supplementary evaluation of the cosmetic effects of a pea extract according to the invention

[0319] Example 3 aims to evaluate additional cosmetic effects of the pea extract obtained according to test 5 of example 1, said extract comprising 4.73 mg / g DW of niacinamide, i.e. 0.473% by weight of niacinamide relative to the dry weight of the extract.

[0320] The tests described below are specifically designed to objectively determine the effect of the extract according to the invention on:

[0321] • lipid accumulation in human sebocytes;

[0322] • the intracellular metabolism of NAD +in human dermal fibroblasts;

[0323] • epidermal renewal;

[0324] • the synthesis of pro-collagen I in a photo-aged human dermal fibroblast model.

[0325] These different mechanisms are involved in skin quality, and in particular in the visibility of pores, skin imperfections, radiance of complexion, epidermal renewal, skin aging, especially photo-induced, and skin laxity.

[0326] 3.1) Effect of the extract according to the invention on lipid accumulation in human sebocytes. Sebaceous glands are glands associated with hair follicles that release sebum onto the skin's surface. Sebum contributes to maintaining skin integrity, notably by reducing water loss and improving skin lubrication. However, excessive lipid production by sebocytes can contribute to an increase in the apparent diameter of pores and an alteration in the overall appearance of the skin.

[0327] The objective of this study is to evaluate the ability of the extract according to the invention to limit lipid accumulation in human sebocytes, after stimulation by oleic acid in order to mimic a situation of increased lipid production.

[0328] Human sebocytes derived from iPSCs, designated PCi-SEB, are thawed in a 37°C water bath and then transferred to a basal medium before centrifugation. The resulting cell pellet is resuspended in supplemented PhenoCULT®-SEB medium. The cells are then counted using a Neubauer chamber and subsequently seeded into 12-well culture chambers pre-coated with fibronectin, at a density of 8 x 10 3 cells per well. The cells are incubated overnight at 37°C under an atmosphere containing 5% CO2.

[0329] The following day, the medium is replaced with fresh medium containing the various experimental treatments. Oleic acid is used at a concentration of 0.05 mg / mL to induce intracellular lipid accumulation. The cells are treated for 72 hours with oleic acid, with or without the extract according to the invention.

[0330] After processing, the cells are washed, fixed, permeabilized, and then labeled with DAPI to visualize cell nuclei and with BODIPY 493 / 503 to visualize intracellular neutral lipids. Images are acquired by confocal microscopy and then analyzed using ZEN and ImageJ software. Quantification is performed by measuring the integrated density of the BODIPY signal, normalized by the number of cell nuclei, to estimate the lipid content per cell.

[0331] [Fig. 9] Figure 9 illustrates the quantification of intracellular lipid accumulation in human PCi-SEB sebocytes, determined by measurement of the BODIPY 493 / 503 signal normalized by the number of cell nuclei, under basal conditions, after stimulation with oleic acid at 0.05 mg / mL, and after stimulation with oleic acid in the presence of different concentrations of the extract according to the invention.

[0332] Oleic acid at 0.05 mg / mL induces a marked increase in intracellular lipid accumulation in PCi-SEB sebocytes, with a 12.4-fold increase in normalized BODIPY signal compared to the untreated control.

[0333] Treatment with the extract according to the invention for 72 hours reduces oleic acid-induced lipid accumulation in a dose-dependent manner. A statistically significant reduction is observed at a 0.3% pea extract concentration, compared to the oleic acid-treated control.

[0334] These results demonstrate that the pea extract according to the invention possesses anti-lipogenic activity, limiting the accumulation of neutral lipids in stimulated human sebocytes. This activity is particularly beneficial for reducing the appearance of oily skin, minimizing skin imperfections, improving overall skin appearance, and reducing the visibility of pores.

[0335] 3.2) Effect of the extract according to the invention on NAD metabolism + in human dermal fibroblasts

[0336] Nicotinamide adenine dinucleotide, or NAD + , is a coenzyme involved in many cellular processes, including redox reactions, energy metabolism, cell signaling, DNA repair and the response to oxidative stress.

[0337] In skin cells, maintaining a satisfactory intracellular pool of NAD + contributes to the maintenance of cellular homeostasis, metabolic flexibility and the response to environmental stresses, particularly oxidative stress.

[0338] The objective of this study is to evaluate the effect of the extract according to the invention on the intracellular level of NAD + in normal human dermal fibroblasts, designated NHDF.

[0339] NHDF fibroblasts are treated for 48 hours with different concentrations of the extract according to the invention. After treatment, the cells are washed with PBS, detached, and then collected. After centrifugation, the cells are lysed using an extraction buffer, with two freeze-thaw cycles, followed by vortexing and high-speed centrifugation to remove insoluble components.

[0340] The supernatants are collected. A portion is used for total protein quantification, while the remainder is filtered to remove protein. Protein-free samples are stored at -80 °C until NAD quantification. + using a NAD / NADH colorimetric kit.

[0341] [Fig. 10] Figure 10 illustrates the intracellular NAD level + in NHDF fibroblasts treated for 48 hours with the pea extract according to the invention.

[0342] Treatment with the pea extract according to the invention induces a dose-dependent increase in intracellular NAD levels + A statistically significant increase was observed at the highest dose tested, with a 28.7% increase in NAD levels. + compared to the untreated control. These results demonstrate that the pea extract according to the invention increases the intracellular availability of NAD + in human dermal fibroblasts. This effect is consistent with the high niacinamide content of the extract according to the invention, niacinamide being a precursor of NAD + .

[0343] Thus, the extract according to the invention contributes to the maintenance of cellular energy metabolism, to the strengthening of redox mechanisms and to the protection of skin cells against oxidative stress, particularly involved in skin aging.

[0344] 3.3) Effect of the extract according to the invention on epidermal renewal. Desquamation is a regulated physiological process that allows the controlled elimination of corneocytes from the surface of the stratum corneum. This process relies in particular on the progressive degradation of corneodesmosomes, structures involved in the cohesion of corneocytes.

[0345] Kallikrein 5, or KLK5, is a serine protease involved in corneodesmosomes' degradation. A controlled increase in its enzymatic activity is associated with stimulation of epidermal cell turnover. Desmoglein 1, or DSG1, is a component of the desmosomes and corneodesmosomes of the stratum corneum. A decrease in its expression reflects a decrease in corneocyte cohesion, consistent with improved desquamation dynamics.

[0346] The objective of this study is to evaluate the effect of the pea extract according to the invention on epidermal renewal, by means of measuring the enzymatic activity of KLK5 and quantifying DSG1 on human skin expiants.

[0347] 2 cm human skin expiatory pieces 2 The excipients are obtained from abdominal surgery performed on a 39-year-old donor with phototype II, after informed consent. The excipients are cultured on metal grids in a suitable medium, at 37°C under a humidified atmosphere containing 5% CO2.

[0348] The expiry date is treated topically with 50 pL / cm² 2Pea extract according to the invention is applied once daily for two consecutive days. Twenty-four hours after the last application, standardized tape stripping is performed using D-Squame® D100 discs, under a pressure of 0.5 kg for 10 seconds. Five successive samples are taken, with samples 2 to 5 being used for protein extraction.

[0349] KLK5 activity is assessed from proteins extracted from samples by tape stripping and incubated with a specific substrate. Fluorescence is measured for 80 minutes at 37°C, and KLK5 activity is calculated from the reaction slope and then normalized by the total protein content. DSG1 is assessed by immunostaining on 5 µm cryostated sections. The sections are incubated with a primary antibody against DSG1, followed by a fluorescent secondary antibody. Nuclei are counterstained with DAPI. Fluorescence images are acquired under identical conditions and then quantified using ImageJ software. The signal intensity is normalized to the analyzed area.

[0350] [Fig. 11] Figure 11 illustrates KLK5 activity (nmol / ug of protein) in the stratum corneum after topical treatment with pea extract according to the invention.

[0351] [Fig. 12] Figure 12 illustrates the level of DSG1 expression (RFU / surface) in human skin expiants after topical treatment with pea extract according to the invention.

[0352] Topical application of the extract according to the invention at 0.57% induces a statistically significant increase in KLK5 activity in the stratum corneum, with an increase of 73.4% compared to the untreated control.

[0353] This increase is associated with a statistically significant decrease in DSG1 expression, with a reduction of 24.9% compared to the untreated control.

[0354] These results demonstrate that the pea extract according to the invention modulates key markers of physiological desquamation, increasing KLK5 activity and reducing DSG1 expression. The extract according to the invention thus promotes controlled epidermal renewal, which helps to improve skin texture, radiance, pore visibility, and skin imperfections.

[0355] 3.4) Effect of the extract according to the invention on the synthesis of pro-collagen I in photo-aged human dermal fibroblasts

[0356] Skin aging is associated with a progressive alteration of the dermal extracellular matrix, particularly a decrease in synthesis and a disorganization of collagen fibers. Type I collagen is one of the main structural components of the dermis and contributes to the firmness, strength, and elasticity of the skin.

[0357] Exposure to ultraviolet radiation, particularly UVB, contributes to skin photoaging by reducing collagen synthesis and promoting its degradation. Stimulating the synthesis of procollagen I, a precursor of mature collagen I, is therefore a particularly promising strategy for preventing and / or combating skin aging, especially photo-induced skin aging.

[0358] The objective of this study is to evaluate the effect of the extract according to the invention on the production of pro-collagen I in normal human dermal fibroblasts, under normal conditions and after UVB exposure. NH DF fibroblasts are detached, counted, and then seeded into 96-well plates. After overnight incubation to allow cell adhesion, the cells are exposed to different concentrations of the pea extract according to the invention for 48 hours.

[0359] For the evaluation of cell viability, the metabolic activity of the cells is determined by MTT test, in order to assess the possible cytotoxic, cytostatic or proliferative effect of the extract.

[0360] For the evaluation of pro-collagen I, cells are cultured under low serum conditions to limit external interferences, then pretreated with the pea extract according to the invention before UVB irradiation at 50 mJ / cm² 2 The cells are subjected to two successive exposures to UVB. After a total incubation period of 48 hours, the supernatants are collected and analyzed by ELISA to quantify the secreted procollagen I. Cell viability is measured in parallel by the MTT assay to normalize procollagen I secretion to the number of viable cells.

[0361] [Fig. 13] Figure 13 illustrates the level of pro-collagen I secreted by non-irradiated NH DF fibroblasts, UVB-irradiated fibroblasts, and UVB-irradiated fibroblasts then treated with the extract according to the invention.

[0362] Exposure to UVB at 50 mJ / cm² 2 This induces a significant decrease in pro-collagen I levels of 38.0% compared to the non-irradiated control. This result confirms that the UVB irradiation protocol used mimics the alterations of the extracellular matrix observed during skin photoaging.

[0363] Under these conditions, treatment with the extract according to the invention at 0.01% induces a significant 49.5% increase in the secretion of procollagen I normalized by cell viability, compared to the untreated UVB-irradiated control.

[0364] These results demonstrate that the extract according to the invention limits the decrease in pro-collagen I synthesis induced by UVB. The extract according to the invention thus exhibits a protective effect against dermal alterations associated with photoaging, and is particularly useful for preventing and / or combating skin aging, improving skin firmness, and preventing sagging.

Claims

DEMANDS 1. Aqueous, hydro-alcoholic or alcoholic extract, preferably aqueous, of at least one plant or at least part of at least one plant of the genus Pisum, said extract comprising at least 0.05%, preferably at least 0.10%, in particular at least 0.20%, and better at least 0.30%, and especially at least 0.40%, by weight of niacinamide relative to the total dry weight of the extract.

2. Extract according to the preceding claim, wherein the plant is of the species Pisum sativum L. or Pisum fulvum Sm, and preferably Pisum sativum L.

3. Extract according to claim 1 or 2, wherein the extract is obtained from at least one plant or at least part of at least one plant having a growth stage between 5 and 20 days, preferably between 7 and 18 days, and better between 9 and 16 days, or even between 11 and 14 days.

4. Extract according to any one of the preceding claims, wherein the extract is obtained from the roots of the plant, the aerial parts of the plant, and mixtures thereof, and preferably from the aerial parts of the plant, and even more preferably from the leaves, stems, flowers and flowering tops, buds, and mixtures thereof.

5. Extract according to any one of the preceding claims, wherein the extract is obtained from at least one plant or at least part of at least one plant having been grown with a photoperiod in which at least part of the lighting comprises visible light illumination and UV light illumination, preferably between 280 and 400 nm, in particular between 280 and 350 nm, and better between 300 and 325 nm.

6. Extract according to any one of the preceding claims, wherein the extract is obtained from at least one plant or from at least a part of at least one plant having been cultivated: - with a photoperiod in which exposure to light is between 15 hours and 24 hours, preferably between 16 hours and 23 hours, better between 17 hours and 22 hours, and particularly between 18 hours and 20 hours; and / or - said photoperiod includes at least one period of exposure under lighting comprising visible light and UV light, continuously or discontinuously, between 10 a.m. and 6 p.m., preferably between 12 p.m. and 4 p.m., and better between 12 p.m. and 2 p.m.; and - Optionally, the period of exposure to UV light is stopped between 1 day and 5 days, preferably between 2 days and 4 days, and better 3 days, before harvest.

7. A method for obtaining at least one extract according to any one of the preceding claims, characterized in that it comprises at least the following steps according to which: (a) at least one plant or at least part of at least one plant of the genus Pisum is available, optionally in crushed and / or frozen form; (b) the plant or plant part from step (a) is subjected to at least one extraction cycle comprising: (b1) at least one microwave extraction step, optionally with stirring; and / or (b2) at least one maceration extraction step, optionally under agitation; preferably step (b1) and step (b2), when both present, being carried out within the same extraction device; (c) Optionally, the extract obtained in step (b) is purified by filtration, ultrafiltration and / or nanofiltration; and (d) Optionally, the extract obtained in step (b), or in step (c), is redispersed in a preservation solvent.

8. A method according to the preceding claim, wherein at least a portion of the photoperiod during the cultivation of the plant in step (a) comprises illumination with visible light and illumination with UV light, preferably between 280 and 400 nm, in particular between 280 and 350 nm, and better between 300 and 325 nm.

9. A method according to claim 7 or 8, wherein the plant of step (a) was cultivated under controlled conditions, preferably in a cultivation unit ensuring control of growing conditions, in particular ensuring controlled regulation of water, humidity, temperature, air quality and light supply, and in particular wherein the plant of step (a) was obtained by hydroponic or aquaponic culture.

10. A method according to any one of claims 7 to 9, wherein the extraction step (b), and in particular step (b1) and / or step (b2), is / are carried out without the addition of extraction solvent, using the plant's native water.

11. A method according to any one of claims 7 to 10, wherein the microwave extraction step (b1) is carried out: - at a power rating between 300 W and 6,000 W, preferably between 600 W and 5,000 W, better between 800 W and 4,000 W, and particularly between 1,000 W and 2,000 W, or even between 300 W and 1,000 W; and / or - for a period of between 1 minute and 180 minutes, preferably between 2 minutes and 120 minutes, better between 5 minutes and 100 minutes, especially between 10 minutes and 60 minutes, or even between 15 minutes and 30 minutes.

12. A method according to any one of claims 7 to 11, wherein the maceration extraction step (b2) is carried out for a period of between 1 minute and 300 minutes, in particular between 5 minutes and 300 minutes, preferably between 10 minutes and 240 minutes, better between 10 minutes and 180 minutes, most particularly between 1 hour and 120 minutes, or even between 10 minutes and 40 minutes.

13. A process according to any one of claims 7 to 12, wherein the process further comprises, after step (b), and preferably after step (b2), at least one solid / liquid separation step (e), in particular by pressing or centrifugation, and / or at least one filtration step (c).

14. Aqueous, hydro-alcoholic or alcoholic extract, preferably aqueous, of at least one plant of the genus Pisum or of at least a part of at least one plant of the genus Pisum, said extract comprising at least 0.05%, preferably at least 0.10%, in particular at least 0.20%, and better at least 0.30%, and most particularly at least 0.40%, by weight of niacinamide relative to the total dry weight of the extract, characterized in that it is capable of being obtained by a process according to any one of claims 7 to 13.

15. Non-therapeutic use, in particular cosmetic use, of at least one extract according to any one of claims 1 to 6, to restore the skin barrier function, prevent and / or combat skin aging, in particular against skin sagging, reduce the visibility of pores and skin imperfections and / or improve skin hydration.

16. Use according to the preceding claim, wherein the extract is administered orally or topically, and preferably topically.

17. Composition, in particular cosmetic, pharmaceutical, nutraceutical or food, and preferably cosmetic, comprising at least one extract according to any one of the preceding claims 1 to 6 or obtained by means of a process of obtaining according to any one of the claims 7 to 13, optionally in association with at least one physiologically acceptable medium.

18. Composition according to the preceding claim, comprising between 0.01% and 20%, preferably between 0.1% and 10%, better between 0.5% and 5%, and particularly between 1% and 3%, by weight of extract(s), relative to the total weight of the composition.

19. Non-therapeutic cosmetic treatment process, in particular for makeup and / or care, of a keratinous material, in particular of the skin, lips or hair, comprising at least one step of applying to said keratinous material at least one extract according to any one of claims 1 to 6 or a composition according to claim 17 or 18.